日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Advances in natural killer cell immunotherapy for hematologic malignancies

血液系统恶性肿瘤自然杀伤细胞免疫疗法的进展

Hu, Huijie; Xiong, Yan; Xia, Minxin; Sheng, Lixia

15-Day Duration of Venetoclax Combined with Azacitidine in Treatment-Naive Higher-Risk Myelodysplastic Syndromes: A Prospective Multicenter Study

维奈托克联合阿扎胞苷治疗初治高危骨髓增生异常综合征15天:一项前瞻性多中心研究

Lai, Binbin; Mei, Chen; Yan, Xiao; Chen, Lieguang; Wang, Yi; Sheng, Lixia; Tang, Shanhao; Mao, Liping; Zhang, Ping; Sun, Yongcheng; Xie, Wanzhuo; Zhou, De; Mai, Wenyuan; Wang, Huafeng; Ma, Liya; Lou, Yinjun; Wu, Wenjun; Jiang, Huifang; Zhang, Jin; Ye, Baodong; Tong, Hongyan; Ouyang, Guifang

Prospective phase II trial of first-line rituximab, methotrexate, and orelabrutinib (R-MO) in primary central nervous system lymphoma

一线利妥昔单抗、甲氨蝶呤和奥拉替尼(R-MO)治疗原发性中枢神经系统淋巴瘤的前瞻性II期试验

Sheng, Lixia; Liu, Hailing; Zhang, Xiaohui; Ding, Kaiyang; Ma, Jie; Peng, Hongling; Zhao, Xia; Sun, Mei; Shi, Wei; Zhang, Feiyan; Li, Jianyong; Cao, Lei; Fan, Lei

High NUP210 mRNA expression and its role in prognosis of acute myeloid leukemia

NUP210 mRNA高表达及其在急性髓系白血病预后中的作用

Wu, An; Yang, Liyun; Yan, Xiao; Lai, Yanli; Chen, Lieguang; Tang, Shanhao; Zhou, Miao; Shi, Cong; Chen, Ying; Sheng, Lixia; Mu, Qitian; Ouyang, Guifang

Identification of biomarkers for chronic lymphocytic leukemia risk: a proteome-wide Mendelian randomization study

慢性淋巴细胞白血病风险生物标志物的鉴定:一项基于蛋白质组的孟德尔随机化研究

Jin, Changyu; Lu, Zehong; Chen, Yuzhan; Hu, Huijie; Zhou, Miao; Zhang, Yanli; Ouyang, Guifang; Li, Tongyu; Sheng, Lixia

NIPA1 depletion in tumor-associated macrophages via IGFBP2/EGFR attenuates acute myeloid leukemia progression and chemoresistance

通过IGFBP2/EGFR途径降低肿瘤相关巨噬细胞中NIPA1的表达,可减弱急性髓系白血病的进展和化疗耐药性。

Tang, Shanhao; Sheng, Lixia; Mu, Qitian; Wang, Yi; Chen, Lieguang; Xu, Kaihong; Zhou, Miao; Xu, Zhijuan; Wu, An; Ouyang, Guifang

A Novel Inflammatory-Nutritional Prognostic Scoring System for Patients with Diffuse Large B Cell Lymphoma

一种用于弥漫性大B细胞淋巴瘤患者的新型炎症-营养预后评分系统

Wang, Zanzan; Bao, Yurong; Xu, Zhijuan; Sun, Yongcheng; Yan, Xiao; Sheng, Lixia; Ouyang, Guifang

Elevated serum direct bilirubin is predictive of a poor prognosis for primary myelodysplastic syndrome

血清直接胆红素升高预示着原发性骨髓增生异常综合征预后不良。

Chen, Ying; Zhou, Danqing; Ma, Chao; Cao, Jie; Ying, Qiming; Sheng, Lixia; Yan, Xiao; Ouyang, Guifang; Mu, Qitian

The gut microbiota correlate with the disease characteristics and immune status of patients with untreated diffuse large B-cell lymphoma

肠道菌群与未经治疗的弥漫性大B细胞淋巴瘤患者的疾病特征和免疫状态相关

Lin, Zhouning; Mao, Dan; Jin, Changyu; Wang, Jiaping; Lai, Yanli; Zhang, Yanli; Zhou, Miao; Ge, Qunfang; Zhang, Ping; Sun, Yongcheng; Xu, Kaihong; Wang, Yi; Zhu, Huiling; Lai, Binbin; Wu, Hao; Mu, Qitian; Ouyang, Guifang; Sheng, Lixia

Decreased transthyretin predicts a poor prognosis in primary myelodysplastic syndrome

转甲状腺素蛋白水平降低预示着原发性骨髓增生异常综合征预后不良

Chen, Ying; Niu, Tingting; Chen, Ting; Wu, Yue; Zou, Duobing; Shi, Cong; Wu, Ying; Zhang, Zhaoyi; Wu, Ningning; Zhang, Yi; Yan, Xiao; Sheng, Lixia; Lv, Dingfeng; Ouyang, Guifang; Chen, Xueqin; Mu, Qitian